$HROW
HARROW, INC.

2024 Q4 Form 10-Q Financial Statement

#000149315224045295 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $49.26M
YoY Change 43.75%
Cost Of Revenue $12.02M
YoY Change 19.38%
Gross Profit $37.24M
YoY Change 53.89%
Gross Profit Margin 75.6%
Selling, General & Admin $33.65M
YoY Change 59.96%
% of Gross Profit 90.35%
Research & Development $2.273M
YoY Change 59.96%
% of Gross Profit 6.1%
Depreciation & Amortization $351.0K
YoY Change 21.03%
% of Gross Profit 0.94%
Operating Expenses $35.92M
YoY Change 59.96%
Operating Profit $1.321M
YoY Change -24.25%
Interest Expense -$5.525M
YoY Change -196.1%
% of Operating Profit -418.24%
Other Income/Expense, Net -$5.521M
YoY Change 20.13%
Pretax Income -$4.200M
YoY Change 47.27%
Income Tax $20.00K
% Of Pretax Income
Net Earnings -$4.220M
YoY Change -3.89%
Net Earnings / Revenue -8.57%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.12
COMMON SHARES
Basic Shares Outstanding 35.61M shares 35.48M shares
Diluted Shares Outstanding 35.70M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $72.60M
YoY Change -1.76%
Cash & Equivalents $72.60M
Short-Term Investments $0.00
Other Short-Term Assets $1.450M
YoY Change 1128.81%
Inventory $10.16M
Prepaid Expenses
Receivables $53.73M
Other Receivables $600.0K
Total Short-Term Assets $147.1M
YoY Change 33.36%
LONG-TERM ASSETS
Property, Plant & Equipment $3.625M
YoY Change -0.11%
Goodwill $332.0K
YoY Change 0.0%
Intangibles $189.3M
YoY Change 16.33%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $204.5M
YoY Change 16.32%
TOTAL ASSETS
Total Short-Term Assets $147.1M
Total Long-Term Assets $204.5M
Total Assets $351.5M
YoY Change 22.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.20M
YoY Change 286.7%
Accrued Expenses $34.67M
YoY Change 58655.93%
Deferred Revenue $137.0K
YoY Change -10.46%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $95.01M
YoY Change 399.26%
LONG-TERM LIABILITIES
Long-Term Debt $186.1M
YoY Change 2.12%
Other Long-Term Liabilities $12.21M
YoY Change 29.93%
Total Long-Term Liabilities $198.3M
YoY Change 3.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $95.01M
Total Long-Term Liabilities $198.3M
Total Liabilities $293.9M
YoY Change 39.52%
SHAREHOLDERS EQUITY
Retained Earnings -$158.2M
YoY Change 26.78%
Common Stock $35.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $57.98M
YoY Change
Total Liabilities & Shareholders Equity $351.5M
YoY Change 22.89%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$4.220M
YoY Change -3.89%
Depreciation, Depletion And Amortization $351.0K
YoY Change 21.03%
Cash From Operating Activities $2.951M
YoY Change -343.88%
INVESTING ACTIVITIES
Capital Expenditures $604.0K
YoY Change -97.0%
Acquisitions
YoY Change
Other Investing Activities $7.000K
YoY Change
Cash From Investing Activities -$597.0K
YoY Change -97.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -721.0K
YoY Change -101.12%
NET CHANGE
Cash From Operating Activities 2.951M
Cash From Investing Activities -597.0K
Cash From Financing Activities -721.0K
Net Change In Cash 1.633M
YoY Change -96.19%
FREE CASH FLOW
Cash From Operating Activities $2.951M
Capital Expenditures $604.0K
Free Cash Flow $2.347M
YoY Change -111.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35168260 shares
dei Amendment Flag
AmendmentFlag
false
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1091 pure
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5166000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
20560000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
159895000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
45030000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
230651000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
37901000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
192750000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-6693000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
186057000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001360214
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2023Q4 HROW Deferred Tax Liability
DeferredTaxLiability
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
HROW Stock Issued During Period Value Restricted Stock Unit Performance Stock Unit Award Gross
StockIssuedDuringPeriodValueRestrictedStockUnitPerformanceStockUnitAwardGross
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q3 HROW Stock Issued During Period Value Performance Stock Unit Award Gross
StockIssuedDuringPeriodValuePerformanceStockUnitAwardGross
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
HROW Purchase Of Product And Related Patents
PurchaseOfProductAndRelatedPatents
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
HROW Proceeds From Repayments Of Loans
ProceedsFromRepaymentsOfLoans
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
HROW Reclassification Of Deferred Financing Costs
ReclassificationOfDeferredFinancingCosts
usd
HROW Accrual Of Exit Fee Related To Oaktree Loan
AccrualOfExitFeeRelatedToOaktreeLoan
usd
HROW Insurance Premium Financed
InsurancePremiumFinanced
usd
HROW Purchase Of Product Associated With Contingent Consideration Payable
PurchaseOfProductAssociatedWithContingentConsiderationPayable
usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023Q4 HROW Prefunded Assistance
PrefundedAssistance
usd
CY2024Q3 HROW Prepaid Prescription Drug User Fees
PrepaidPrescriptionDrugUserFees
usd
CY2024Q3 HROW Capitalized Computer Software Internal Use In Process
CapitalizedComputerSoftwareInternalUseInProcess
usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35814
dei Entity Registrant Name
EntityRegistrantName
Harrow, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0567010
dei Entity Address Address Line1
EntityAddressAddressLine1
1A Burton Hills Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37215
dei City Area Code
CityAreaCode
(615)
dei Local Phone Number
LocalPhoneNumber
733-4730
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35614718 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72601000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74085000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
8681000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53734000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36261000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
10156000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10867000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10571000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9588000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
147062000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
139482000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3625000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3521000 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1869000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2138000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9379000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6785000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
189272000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
159906000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
332000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
332000 usd
CY2024Q3 us-gaap Assets
Assets
351539000 usd
CY2023Q4 us-gaap Assets
Assets
312164000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
25277000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24581000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37000000 usd
CY2024Q3 HROW Accrued Rebates And Copay Assistance
AccruedRebatesAndCopayAssistance
24899000 usd
CY2023Q4 HROW Accrued Rebates And Copay Assistance
AccruedRebatesAndCopayAssistance
18432000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7185000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5450000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
137000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
75000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
507000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
806000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
95005000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49344000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9500000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6524000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
2713000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
2713000 usd
CY2024Q3 HROW Deferred Tax Liability
DeferredTaxLiability
643000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
186057000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
183172000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
293918000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
241753000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35611365 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35611365 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35168260 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
35000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
35000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
216103000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
204635000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-158162000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133904000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
57976000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
70766000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-355000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-355000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57621000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
70411000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
351539000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
312164000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49257000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34265000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132783000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93838000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12018000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10067000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35110000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28338000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
37239000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
24198000 usd
us-gaap Gross Profit
GrossProfit
97673000 usd
us-gaap Gross Profit
GrossProfit
65500000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33645000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21033000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
94275000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56878000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2273000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1421000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7475000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3316000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
35918000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
22454000 usd
us-gaap Operating Expenses
OperatingExpenses
101750000 usd
us-gaap Operating Expenses
OperatingExpenses
60194000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1321000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1744000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4077000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5306000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5525000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5749000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
16411000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
16200000 usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
1348000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-3171000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
2676000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5465000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-195000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
76000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-344000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5521000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4596000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19506000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19333000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4200000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2852000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23583000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14027000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1539000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
675000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1236000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4220000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4391000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24258000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15263000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35702200 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35702200 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34255197 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34255197 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35597409 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35597409 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31689947 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31689947 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27240000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64520000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
85000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
270000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-12971000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11521000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15263000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
75402000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
70411000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1005000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-2362000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12825000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24258000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57621000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22052000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64520000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
18000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-11273000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4476000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4391000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
75402000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58177000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58177000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
484000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-1205000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4385000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4220000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57621000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57621000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24258000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15263000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1382000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1095000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7708000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7634000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
636000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
541000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-20000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
68000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2985000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2568000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-3171000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
2676000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5465000 usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-22000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
12825000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11521000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
643000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17453000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12287000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-711000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2383000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
983000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4079000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6433000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1584000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1735000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1294000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
62000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
40000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4423000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4856000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
5510000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
74000 usd
HROW Purchase Of Product And Related Patents
PurchaseOfProductAndRelatedPatents
-151084000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1040000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1266000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4396000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-152350000 usd
CY2023Q3 HROW Notes Payable Percent
NotesPayablePercent
0.11875 pure
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4961000 usd
HROW Proceeds From Repayments Of Loans
ProceedsFromRepaymentsOfLoans
73552000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
100000 usd
HROW Payment Of Payroll Taxes Upon Vesting Of Ps Us Rs Us And Exercise Of Stock Options
PaymentOfPayrollTaxesUponVestingOfPSUsRSUsAndExerciseOfStockOptions
2362000 usd
HROW Payment Of Payroll Taxes Upon Vesting Of Ps Us Rs Us And Exercise Of Stock Options
PaymentOfPayrollTaxesUponVestingOfPSUsRSUsAndExerciseOfStockOptions
12971000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1005000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
355000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
55879000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
59750000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
64520000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1457000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
126546000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1484000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30660000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74085000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96270000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72601000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65610000 usd
us-gaap Interest Paid Net
InterestPaidNet
15553000 usd
us-gaap Interest Paid Net
InterestPaidNet
12279000 usd
HROW Reclassification Of Deferred Financing Costs
ReclassificationOfDeferredFinancingCosts
1950000 usd
HROW Accrual Of Exit Fee Related To Oaktree Loan
AccrualOfExitFeeRelatedToOaktreeLoan
2713000 usd
HROW Insurance Premium Financed
InsurancePremiumFinanced
1321000 usd
HROW Purchase Of Product Associated With Contingent Consideration Payable
PurchaseOfProductAssociatedWithContingentConsiderationPayable
37000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
177000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3230000 usd
HROW Consolidation Basis Description
ConsolidationBasisDescription
(i) entities in which it holds and/or controls, directly or indirectly, more than 50% of the voting rights
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
53734000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
281000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
371000 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-20000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
70000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
281000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-3171000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4220000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4391000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24258000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15263000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35702200 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35702200 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34255197 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34255197 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35597409 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35597409 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31689947 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31689947 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0295 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0881 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49257000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34265000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132783000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93838000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
137000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
75000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5306000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5477000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
176000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
54000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4674000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5336000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
10156000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10867000 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
1639000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1241000 usd
CY2024Q3 HROW Prepaid Computer Software Licenses And Related Expenses
PrepaidComputerSoftwareLicensesAndRelatedExpenses
619000 usd
CY2023Q4 HROW Prepaid Computer Software Licenses And Related Expenses
PrepaidComputerSoftwareLicensesAndRelatedExpenses
1613000 usd
CY2024Q3 HROW Prefunded Assistance
PrefundedAssistance
4514000 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1749000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
906000 usd
CY2024Q3 HROW Receivable Due From Related Party
ReceivableDueFromRelatedParty
228000 usd
CY2023Q4 HROW Receivable Due From Related Party
ReceivableDueFromRelatedParty
228000 usd
CY2023Q4 HROW Prepaid Prescription Drug User Fees
PrepaidPrescriptionDrugUserFees
3438000 usd
CY2024Q3 HROW Deferred Commitment Fee
DeferredCommitmentFee
372000 usd
CY2023Q4 HROW Deferred Commitment Fee
DeferredCommitmentFee
409000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1450000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1753000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10571000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9588000 usd
CY2024Q3 HROW Computer Hardware Gross
ComputerHardwareGross
1477000 usd
CY2023Q4 HROW Computer Hardware Gross
ComputerHardwareGross
1322000 usd
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
965000 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
936000 usd
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5304000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4564000 usd
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
6899000 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
6771000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14645000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13593000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11020000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10072000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3625000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3521000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
351000 usd
us-gaap Depreciation
Depreciation
948000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
290000 usd
us-gaap Depreciation
Depreciation
743000 usd
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3571000 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2939000 usd
CY2024Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1702000 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1268000 usd
CY2023Q4 HROW Capitalized Computer Software Internal Use In Process
CapitalizedComputerSoftwareInternalUseInProcess
467000 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1869000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2138000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
209013000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-19741000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
189272000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2605000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2584000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7708000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7634000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4025000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
16630000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
16630000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
16281000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
15933000 usd
CY2024Q3 HROW Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
119547000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
189046000 usd
CY2024Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 usd
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 usd
CY2023Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 usd
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 usd
CY2024Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
23202000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
21424000 usd
CY2024Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
21000 usd
CY2023Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
873000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
106000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
306000 usd
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1948000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1978000 usd
CY2024Q3 HROW Accrued Exit Fee For Loan Current And Non Current
AccruedExitFeeForLoanCurrentAndNonCurrent
2713000 usd
CY2023Q4 HROW Accrued Exit Fee For Loan Current And Non Current
AccruedExitFeeForLoanCurrentAndNonCurrent
2713000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
27990000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
27294000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
25277000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24581000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
2713000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
2713000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
192750000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
192750000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-6693000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-9578000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
186057000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
183172000 usd
CY2024Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1103 pure
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1117 pure
CY2023Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1078 pure
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785 pure
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y4M24D
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
327000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
972000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
310000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
921000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
329000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1386000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1767000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1641000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1342000 usd
CY2024Q3 HROW Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
7971000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14436000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4429000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10007000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
507000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9500000 usd
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
1.47
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
39.63
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2480389 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y5M8D
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
6.33
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2218148 shares
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
5.50
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4385000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4476000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12825000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11521000 usd
CY2023Q3 HROW Reduction In Milestone Amounts
ReductionInMilestoneAmounts
550000 usd
HROW Reduction In Milestone Amounts
ReductionInMilestoneAmounts
550000 usd
HROW Reduction In Milestone Amounts
ReductionInMilestoneAmounts
550000 usd
HROW Reduction In Milestone Amounts
ReductionInMilestoneAmounts
550000 usd
CY2023Q3 HROW Payment For Milestone
PaymentForMilestone
4450000 usd
HROW Payment For Milestone
PaymentForMilestone
4450000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49257000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12018000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
37239000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1321000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34265000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10067000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
24198000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1744000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132783000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35110000 usd
us-gaap Gross Profit
GrossProfit
97673000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4077000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93838000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28338000 usd
us-gaap Gross Profit
GrossProfit
65500000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5306000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49257000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34265000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132783000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93838000 usd

Files In Submission

Name View Source Status
hrow-20240930_def.xml Edgar Link unprocessable
0001493152-24-045295-index-headers.html Edgar Link pending
0001493152-24-045295-index.html Edgar Link pending
0001493152-24-045295.txt Edgar Link pending
0001493152-24-045295-xbrl.zip Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
hrow-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
hrow-20240930_cal.xml Edgar Link unprocessable
hrow-20240930_lab.xml Edgar Link unprocessable
hrow-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable